Skip to main content
Log in

Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives

  • Originals
  • Published:
Diabetologia Aims and scope Submit manuscript

Summary

In this study we investigated whether fat cell lipolysis could be involved in the aetiology of obesity by comparing non-obese subjects with (Hob) or without (Hnorm) a family trait for overweight. A family history of obesity was present when at least one of the first-degree relatives had body mass index of 27 kg/m2 or more. Twenty-seven healthy, drugfree non-obese adult subjects were investigated; 13 were Hob and the remaining 14 were Hnorm. Eleven Hob had at least one obese parent. Isolated fat cells from abdominal subcutaneous adipose tissue were incubated in vitro. Glycerol release (lipolysis index), mRNA levels and enzymatic activity of hormone-sensitive lipase and radioligand binding to beta1- and beta2-adrenoceptors were determined. The lipolytic effects of noradrenaline (major endogenous lipolytic agent), isoprenaline (a non-selective beta-adrenoceptor agonist), forskolin (a direct activator of adenylyl cyclase) and dibutyryl cyclic AMP (activating protein kinase and thereby hormone-sensitive lipase) were reduced by about 50% (p from 0.001 to 0.01). The maximum activity of hormone-sensitive lipase was reduced 50% in Hob (p<0.05) and correlated with the lipolytic responsiveness of fat cells in the whole population (r=0.71). However, there was no difference between the groups in steady-state mRNA levels for the enzyme. Beta1-, beta2- and alpha2-adrenoceptor sensitivity as well as beta1- and beta2-adrenoceptor numbers were normal in Hob. Fasting plasma insulin was 49.1 and 32.6 pmol/l, respectively in Hob and Hnorm (p=0.01). There was, however, no significant correlation between lipolysis in vitro and plasma insulin. Thus, lipolytic catecholamine resistance in fat cells, at least partly due to impaired function of hormone-sensitive lipase, is an adipocyte abnormality associated with a family tendency to obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bouchard C, Pérusse L (1993) Genetics of obesity. Annu Rev Nutr 337–354

  2. Sörensen TIA (1992) Genetic aspects of obesity. Int J Obesity [Suppl 2]: S27–S29

  3. Bouchard C, Després JP, Mauriège P (1993) Genetic and nongenetic determinants of regional fat distribution. Endocrine Rev 14: 72–93

    CAS  Google Scholar 

  4. Lafontan M, Berlan M (1993) Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34: 1057–1092

    PubMed  CAS  Google Scholar 

  5. Giacobino JP (1995) Beta3-adrenoceptor: an update. Eur J Endocrinol 132: 377–385

    Article  PubMed  CAS  Google Scholar 

  6. Lönnqvist F, Krief S, Strosberg AD, Nyberg B, Emorine L, Arner P (1993) Evidence for a functional beta3-adrenoceptor in man. Br J Pharmacol 110: 929–936

    PubMed  Google Scholar 

  7. Wolffe RR, Peters EJ, Klein S, Holland OB, Rosenblatt J, Gary H (1987) Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects. Am J Physiol 2523: E189-E196

    Google Scholar 

  8. Jensen MD, Haymond HW, Rizza RA, Cryer PE, Miles JM (1989) Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83: 1167–1173

    Article  Google Scholar 

  9. Connacher AA, Bennet WM, Jung RT et al. (1991) Effect of adrenaline infusion on fatty acid and glucose turnover in lean and obese human subjects in post-absorptive and fed states. Clin Sci 81: 635–644

    PubMed  CAS  Google Scholar 

  10. Reynisdottir S, Wahrenberg H, Carlström K, Rössner S, Arner P (1994) Catecholamine-resistance in fat cells of upper-body obese women due to decreased expression of beta2-adrenoceptors. Diabetologia 37: 428–435

    Article  PubMed  CAS  Google Scholar 

  11. Mauriége P, Després JP, Prud'homme D et al. (1991) Regional variation in adipose tissue lipolysis in lean and obese men. J Lipid Res 32: 1625–1633

    PubMed  Google Scholar 

  12. Reynisdottir S, Ellerfeldt K, Wahrenberg H, Lithell H, Arner P (1994) Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest 93: 2590–2599

    Article  PubMed  CAS  Google Scholar 

  13. Bray GA (1987) Overweight is risking fate. Definition, classification, prevalence and risks. Ann N Y Acad Sci 499: 14–28

    Article  PubMed  CAS  Google Scholar 

  14. Kolaczynski JW, Morales LM, Moore JH et al. (1994) A new technique for biopsy of human abdominal fat under local anaesthesia with lidocaine. Int J Obesity 18: 161–166

    CAS  Google Scholar 

  15. Hellmér J, Arner P, Lundin A (1989) Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal Biochem 177: 132–137

    Article  PubMed  Google Scholar 

  16. östman J, Arner P, Kimura H, Wahrenberg H, Engfeldt P (1984) Influence of fasting on lipolytic response to adrenergic agonists and on adrenergic receptors in subcutaneous adipocytes. Eur J Clin Invest 13: 383–391

    Article  Google Scholar 

  17. Kenakin T (1984) The classification of drugs and drug receptors in isolated tissue. Pharm Rev 36: 165–214

    PubMed  CAS  Google Scholar 

  18. Reynisdottir S, Eriksson M, Angelin B, Arner P (1995) Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. J Clin Invest 95: 2161–2169

    Article  PubMed  CAS  Google Scholar 

  19. Scatchard G (1948) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672

    Article  Google Scholar 

  20. Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal Biochem 107: 220–239

    Article  PubMed  CAS  Google Scholar 

  21. Fredriksson G, Strålfors P, Nilsson Nö, Belfrage P (1981) Hormone-sensitive lipase from rat. Methods Enzymol 71: 636–646

    Article  Google Scholar 

  22. Frayn KN, Langin D, Holm C, Belfrage P (1993) Hormone-sensitive lipase: quantitation of enzyme activity and mRNA in small biopsies of human adipose tissue. Clin Chim Acta 216: 183–189

    Article  PubMed  CAS  Google Scholar 

  23. Arner P, Hellström L, Wahrenberg H, Brönnegård M (1990) Beta-adrenoceptor expression in human fat cells from different regions. J Clin Invest 86: 1595–1600

    Article  PubMed  CAS  Google Scholar 

  24. Lönnqvist F, Wahrenberg H, Hellström L, Reynisdottir S, Arner P (1992) Lipolytic catecholamine resistance due to decreased beta2-adrenoceptor expression in fat cells. J Clin Invest 90: 2175–2186

    Article  PubMed  Google Scholar 

  25. Engfeldt P, Hellmér J, Wahrenberg H, Arner P (1988) Effects of insulin on adrenoceptor binding and the role of catecholamine-induced lipolysis in isolated human fat cells. J Biol Chem 263: 15553–15560

    PubMed  CAS  Google Scholar 

  26. Smith U (1974) Studies of human adipose tissue in culture. III. Influence of insulin and medium glucose concentration on cellular metabolism. J Clin Invest 53: 91–98

    Article  PubMed  CAS  Google Scholar 

  27. Kang ES, Betts D, Fain JN, Bahouth SW, Myers LK (1993) Chronic exposure of rat fat cells to insulin enhances lipolysis and activation of partially purified hormone-sensitive lipase. Diabetes 42: 1415–1424

    Article  PubMed  CAS  Google Scholar 

  28. Landerholm TE, Stern J (1992) Adipose tissue lipolysis in vitro: a predictor of diet-induced obesity in female rats. Am J Physiol 32: R1248-R1253

    Google Scholar 

  29. Lönnqvist F, Nyberg B, Wahrenberg H, Arner P (1990) Catecholamine-induced lipolysis in adipose tissue of the elderly. J Clin Invest 85: 1614–1621

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hellström, L., Langin, D., Reynisdottir, S. et al. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives. Diabetologia 39, 921–928 (1996). https://doi.org/10.1007/BF00403911

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00403911

Keywords

Navigation